Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

506 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Active, not recruiting

Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes

NCT04802161

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemia With Multilineage Dysplasia, +19 more
Locations
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)

NCT04509700

Conditions
B-cell Malignancies, Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations
  • Uab Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Rochester Phoenix, Arizona, United States
  • University of Arizona Cancer Center-Out Pt. Tucson, Arizona, United States
View all 105 locations
View Trial Details

Related conditions